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Antibodies have been prepared against he 2-oxoglutarate ransport proteins purified from bovine heart and rat liver mitochondria. The anti-heart 
antiserum cross-reacts with the 2-oxoglutarate carrier (OGC) from beef, pig, rat and rabbit heart, but not with the OGC from liver of the same 
animals. Conversely, the anti-liver antiserum recognizes the carrier protein from liver of all species tested but not from heart. Immunoinactivation 
of oxoglutarate transport activity by the antibodies i  also tissue specific. Peptide maps of purified OGC show structural differences between the 
carrier from heart and liver of the same animal species. These results indicate the existence of isoforms of the OGC in heart and liver. 
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1. INTRODUCTION 
The OGC, an intrinsic protein of the inner mitochon- 
drial membrane, catalyzes an exchange between 
2-oxoglutarate and malate, which is important for 
several metabolic processes uch as gluconeogenesis 
from lactate and the malate-aspartate shuttle (for 
reviews see [1,2]). Unlike other mitochondrial anion- 
transporting systems uch as the dicarboxylate and the 
citrate carrier, the OGC has a high activity both in liver 
and heart. In our laboratory we have isolated and func- 
tionally reconstituted the 2-oxoglutarate ransport pro- 
tein from both heart and liver mitochondria [3-5]. 
Whereas the functional properties of the OGC have 
been investigated both in mitochondria nd in pro- 
teoliposomes, little is known about the structure of this 
carrier. We have recently shown that essential 
sulphydryl groups are located at the cytosolic face of 
the OGC in the vicinity of the substrate-binding site [6]. 
In order to obtain further insight into the structure and 
function of the OGC we have prepared specific an- 
tibodies against he carrier purified from bovine heart 
and rat liver mitochondria. The anti-heart antiserum 
cross-reacts with the OGC from heart of various species 
but does not recognize the carrier protein from liver 
even from the same species. A completely opposite 
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cross-reactivity is exhibited by the anti-liver antiserum. 
It is concluded that the antigenic properties of the OGC 
are markedly tissue specific. 
2. MATERIALS AND METHODS 
Nitrocellulose membrane filters (BA 85) were purchased from 
Schleicher and Schuell, peroxidase-conjugated anti-rabbit lg and 
[1-~4C]2-oxoglutarate from Amersham International, Tween 20 from 
Sigma, microtitration polystyrene plates from Nunc, proteinase K
and pronase from Boehringer, protein A-Sepharose CL-4B from 
Pharmacia. All other reagents were of analytical grade. 
Mitochondria from different organs and species were prepared by 
standard procedures. The OGC from heart and liver of several mam- 
mals was purified in 3% Triton X-114 essentially as described 
previously [3,5]. For the preparation of the antisera, the OGC pro- 
teins from bovine heart and rat liver were electroeluted from SDS 
preparative gels containing 17.5% acrylarnide and an 
acrylamide:bisacrylamide ratio of 150. After collection of preim- 
mune sera, 0.2 mg of OGC from bovine heart or rat liver was dissolv- 
ed in 0.5 ml of 0.9°7o NaC1, emulsified with an equal volume of 
complete Freund's adjuvant and injected subcutaneously at multiple 
sites into the backs of rabbits. Four weeks after the first injection, a 
booster injection of 0.2 mg of antigen emulsified in incomplete 
Freund's adjuvant was given intramuscularly into the flank. Blood 
was collected from the marginal ear vein after 2 weeks and serum was 
obtained by centrifugation of blood that had been left to clot at room 
temperature for 2 h. Where specified, IgG was purified from the an- 
tisera by affinity chromatography on protein A-Sepharose CL-4B. 
The reactivity of the antibodies was tested by ELISA and by im- 
munoblotting according to standard procedures. For the immu- 
noinactivation experiments, the purified OGC from bovine heart or 
rat liver (15 ,ug of protein) was incubated with purified IgG in a final 
volume of 0.5 ml containing 0.8% (w/v) Triton X-114, 20 mM Pipes 
and 20 mM NazSO4, pH 7.0. After 3 h incubation in ice, the samples 
were assayed for oxoglutarate transport activity in reconstituted 
liposomes, as described previously [5]. Protease digestion of purified 
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OGC proteins (5-10 gzg) was performed, after precipitation with 1007o 
TCA, in 100/zl of buffers (0.1 M sodium borate-HC1, pH 7.5, 5 mM 
CaC12, 0.1°70 SDS and 0.1/~g of pronase, or 50 mM Tris-HC1, pH 
8.0, 0.1070 SDS and 0.5 ng of proteinase K) for 30 min at 40°C (pro- 
nase) or at room temperature (proteinase K). The reaction was stop- 
ped by addition of 2°7o SDS plus 100 mM dithioerythritol and boiling 
for 2 min. The proteolytic products were separated byelectrophoresis 
on a linear gradient acrylamide g l (10-20070) and stained with the 
silver nitrate method [7]. Protein was determined by a modified 
Lowry method [8]. 
3. RESULTS 
In preliminary experiments the two polyclonal an- 
tisera raised against the purified OGC from bovine 
heart and rat liver were characterized by ELISA. The 
anti-heart antiserum produced a positive response 
against 0.1/zg of purified OGC from bovine heart up 
to a dilution of 1:6000. With the anti-liver antiserum 
the immunoreaction was still detectable at 1 : 5000 dilu- 
tion in the presence of the same amount of purified 
OGC from rat liver. In both cases no reaction was 
found with the preimmune sera even at a dilution of 
I : I00. 
In order to investigate whether the antisera were able 
to affect the activity of the OGC, purified IgG was in- 
cubated with the solubilized OGC isolated from bovine 
heart or rat liver. After this incubation the mixtures 
were tested for oxoglutarate transport activity in 
reconstituted liposomes. The anti-heart IgG inhibited 
the reconstituted OGC activity when incubated with the 
bovine heart protein, but not with the rat liver protein 
(Fig. 1). Conversely, the anti-liver IgG strongly 
decreased the reconstituted transport activity of the 
OGC from rat liver, without affecting the activity of 
the OGC from bovine heart (Fig. 1). It should be noted 
that, under the experimental conditions used in these 
experiments (presence of Triton X-114 and non- 
optimal salt concentrations), the OGC proteins were 
not immunoprecipitated by the specific antibodies. 
This is supported by the following observations: (a) 
centrifugation of the incubation mixtures was not re- 
quired to observe the reported inhibitions nor increased 
the degree of inhibition, and (b) the immunoblots of 
the supernatants and pellets obtained from the incuba- 
tion mixtures by centrifugation showed the presence of 
the immunoreactive material only in the supernatants. 
Clearly the antigen/antibody complex is unable to 
reconstitute the transport activity in liposomes. As 
shown in Fig. 1A and B, incubation of the purified IgG 
with the liposomes reconstituted with the bovine heart 
or the rat liver OGC did not cause any inhibition of the 
oxoglutarate transport activity, probably because the 
antigenic determinants are not sufficiently exposed on 
the external surface of the liposomes. 
The ability of the immune sera to react with the 
mitochondrial OGC of different species and tissues was 
investigated by Western blot analysis. In these ex- 
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Fig. 1. Effects of antibodies on the reconstituted oxoglutarate 
transport activity of bovine heart OGC and of rat liver OGC. The 
OGC from bovine heart in A and from rat liver in B were incubated 
in the solubilized state with anti-heart OGC IgG (e) or with anti- 
liver OGC IgG (©). In (×) the OGC from bovine heart (A) and from 
rat liver (B) were incubated after econstitution into liposomes with 
anti-heart OGC IgG or anti-liver OGC IgG, respectively. The control 
value of uninhibited oxoglutarate transport was 17 mmol/6 rain per 
g protein in A (at 1 mM external substrate) and 6 mm01/10 min per 
g protein in B (at 0.1 mM external substrate). 
purified OGCs were solubilized in 1°70 SDS, elec- 
trophoresed, transferred onto nitrocellulose and in- 
cubated with the anti-heart or the anti-liver OGC 
antiserum, Fig. 2A shows that the anti-heart antiserum 
cross-reacted with a single band in heart mitochondria 
of all the species tested. The immunodecorated band 
had an Mr of 31 500 in beef and pig and 31 kDa in rat 
and rabbit. These molecular weights are identical to 
those of the OGC isolated from porcine and bovine 
hearts [3,4] and of the OGC isolated from rat heart (see 
Fig. 3). In contrast, there was no cross-reactivity of the 
bovine heart antiserum with the pure OGC isolated 
from the liver of the same species (Fig. 2A) nor with 
any protein of solubilized liver mitochondria from beef 
(Fig. 2A), pig, rat and rabbit (not shown). As shown in 
Fig. 2B, the liver antiserum reacted with the OGC pre- 
sent in liver mitochondria of all the species tested, 
although with a lower affinity for beef and pig. The 
OGC from rat liver had an Mr of 32500 as previously 
demonstrated [5], whereas the OGC from bovine and 
porcine liver had the same mobility as the OGC 
previously isolated from the heart of pig and beef ([3,4] 
and Fig. 3 of the present paper). In striking contrast 
with the above results, the rat liver antiserum did not 
react at all with the heart OGC of the same species 
(Fig. 2B) as well as with the OGC of bovine, porcine 
and rabbit hearts (not shown). In other experiments 
(not shown) it was found that both the heart and the 
liver antiserum reacted only weakly with the renal 
OGC, i.e. with a single band of 31.5 kDa in kidney 
mitochondria from beef, pig, rat and rabbit. It should 
be noted that the absence of cross-reactivity between 
heart and liver, and the weak reactivity with kidney, 
were confirmed by immunoblot experiments in which 
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Fig. 2. Immunological ross-reactivity of OGC proteins. Samples were separated on a 17.5% polyacrylamide geland transferred to nitrocellulose. 
(A) Immunodecoration with anti-heart OGC antiserum (diluted 1 : 1000). (B) lmmunodecoration with anti-liver OGC antiserum (diluted 1:800). 
100/zg of SDS solubilized heart mitochondria from beef (BH), pig (PH), rat (RH) and rabbit (Rail) or 100/~g of SDS solubilized liver 
mitochondria from beef (BL), pig (PL), rat (RL) and rabbit (RaL) or 1/zg of purified OGC from liver and heart of beef (BL and BH) and rat 
(RL and RH) were applied to the gel. 
we used concentrations of carrier protein and of an- 
tibodies 5 times higher than those applied in Fig. 2A 
and B. 
In order to search for structural differences between 
the liver and the heart OGC more directly, we com- 
pared the products obtained by proteolytic fragmenta- 
tion of the purified proteins. In Fig. 3 the peptide maps 
produced by pronase digestion of the heart and liver 
OGC from beef and rat are presented. The peptide pat- 
M BH RH RL BL  
Fig. 3. Peptide maps of OGC obtained by incubating purified carrier 
proteins with pronase. M, markers (bovine serum albumin, carbonic 
anhydrase and cytochrome c).Other abbreviations a  in Fig. 2. 
terns of the heart OGC were very similar taking into ac- 
count that the uncleaved protein from rat, and the 
fragments derived from it, were all smaller than the 
corresponding polypeptides from beef. The peptide 
maps of the OGC from rat and bovine liver were only 
partly similar. A clear difference, however, could be 
observed between the peptide patterns of the OGC 
isolated from the hearts and the livers (Fig. 3). Essen- 
tially the same conclusions were reached by comparing 
the peptide maps of the OGC produced by proteinase 
K instead of pronase (results not shown). 
4. DISCUSSION 
In this study we have prepared two antisera for the 
immunochemical characterization f the OGC present 
in heart and liver of different mammals. The results in- 
dicate the existence of an organ specificity of the an- 
tigenic properties of the OGC. The anti-heart 
antibodies react with the OGC in heart of all animals 
tested but not with the OGC in liver of the same 
animals. This is documented by both the immunoinac- 
tivation and the immunoblot experiments (Figs. 1 and 
2). The organ specificity of the OGC is further sup- 
ported by the parallel experiments where the antiserum 
raised against he OGC purified from rat liver has been 
used. In this case, the antibodies react with the carrier 
protein in all liver samples tested, although with differ- 
ing affinities, but not in heart samples even from the 
same species. It appears therefore that the OGC differs 
immunologically more in the two tissues liver and heart 
from the same animal than in the same tissue from dif- 
ferent animal species. These results demonstrate that 
the antigenic determinants of the OGC from heart and 
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liver are tissue specific. The peptide patterns of the 
OGC from heart and liver of the same organism show 
indeed some differences in their pr imary sequence 
(Fig. 3). 
Tissue-specific differences of mitochondrial  anion- 
transport ing systems have so far been demonstrated on- 
ly for the ADP/ATP  carrier by immunological  studies 
[9] as well as cDNA sequence analysis [10-15]. It is in- 
teresting that in addit ion to tissue-specific also 
conformation-specif ic antibodies could be raised in 
rabbits against the ADP/ATP  carrier [16]. Tissue- 
specific as well as developmental-specific isoforms were 
also shown for nucleus-encoded subunits of 
cytochrome c oxidase by immunological  studies [17], 
which were verified by cDNA sequences [18]. 
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